Evaluation of the Quantase™ neonatal immunoreactive trypsinogen (IRT) screening assay for cystic fibrosis

Articles in the same Issue

1. Second Santorini Conference “From Human Genetic Variations to Prediction of Risks and Responses to Drugs and to the Environment”
2. Expressed genome molecular signatures of heart failure
3. Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice
4. Alcohol and gene interactions
5. β-Carotene stimulates chemotaxis of human endothelial progenitor cells
6. Effect of interferon-γ, interleukin-10, lipopolysaccharide and tumor necrosis factor-α on chitotriosidase synthesis in human macrophages
7. Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients
8. Apolipoprotein E haplotyping by denaturing high-performance liquid chromatography
9. Both core and terminal glycosylation alter epitope expression in thyrotropin and introduce discordances in hormone measurements
10. Do we measure bilirubin correctly anno 2005?
11. Differences in mortality on the basis of laboratory parameters in an unselected population at the Emergency Department
12. An Italian program of external quality control for quantitative assays based on real-time PCR with Taq-Man™ probes
13. A reference material for traceability of aspartate aminotransferase (AST) results
14. Harmonization of the Bayer ADVIA Centaur and Abbott AxSYM automated B-type natriuretic peptide assay in patients on hemodialysis
15. Multicenter evaluation of the analytical and clinical performance of the Elecsys ^® S100 immunoassay in patients with malignant melanoma
16. Guidelines for sampling, measuring and reporting ionized magnesium in undiluted serum, plasma or blood: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC): IFCC Scientific Division, Committee on Point of Care Testing
17. Evaluation of the Quantase™ neonatal immunoreactive trypsinogen (IRT) screening assay for cystic fibrosis